Vfend and hepatic function abnormal 
Vfend and hepatic function abnormal Patient Reports February 12, 2012
Vfend Side Effects Report #4603320-0
Vfend side effect was reported by a Health Professional from on Feb 22, 2005. Female patient, 50 years of age, was diagnosed with respiratory tract infection fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: aggression, agitation, confusional state, euphoric mood, hallucination, hepatic function abnormal. Vfend dosage: 400 M G (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with PREDNISONE, AMPHOTERICINE B, TEICOPLANIN, FILGRASTIM, ALPRAZOLAM, LANSOPRAZOLE. Patient recovered.
Vfend Side Effects Report #5369665-4
Vfend side effect was reported by a Physician from JAPAN on June 13, 2007. Female patient, 86 years of age, was diagnosed with respiratory moniliasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion, hepatic function abnormal. Vfend dosage: DAILY DOSE:400MG. Patient died on 06/01/2007.
Vfend Side Effects Report #4788876-X
Vfend side effect was reported by a Physician from JAPAN on Sept 21, 2005. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with pulmonary mycosis, lung infection, pyrexia and was treated with Vfend. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dehydration, diabetes mellitus inadequate control, dialysis
, haemodialysis, hepatic function abnormal, hyperglycaemia, lung infection. Vfend dosage: 400 MG (BID), INTRAVENOUS. During the same period patient was treated with CLINDAMYCIN PHOSPHATE, TIENAM, LOXONIN, VENOGLOBULIN, MODACIN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4809975-X
Vfend side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with pulmonary mycosis, lung infection, pyrexia and was treated with Vfend. After drug was administered, patient experienced the following side effects: dehydration, diabetes mellitus inadequate control, emphysema, fungus sputum test positive, haemodialysis, hepatic function abnormal, renal failure acute. Vfend dosage: 400 MG (BID), INTRAVENOUS. During the same period patient was treated with CLINDAMYCIN PHOSPHATE, TIENAM, LOXONIN, VENOGLOBULIN, MODACIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #4810360-5
Vfend side effect was reported by a Physician from JAPAN on Oct 11, 2005. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with pulmonary mycosis, lung infection, pyrexia and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood potassium increased, dehydration, diabetes mellitus inadequate control, fungus sputum test positive, haemodialysis, hepatic function abnormal, pyrexia. Vfend dosage: 400 MG (BID), INTRAVENOUS. During the same period patient was treated with CLINDAMYCIN PHOSPHATE, TIENAM, LOXONIN, VENOGLOBULIN, MODACIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #4845005-1
Vfend side effect was reported by a Physician from JAPAN on Nov 16, 2005. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with pulmonary mycosis, lung infection, pyrexia and was treated with Vfend. After drug was administered, patient experienced the following side effects: dehydration, diabetes mellitus inadequate control, fungus sputum test positive, hepatic function abnormal, lung infection, pneumonia
, pyrexia, renal failure acute. Vfend dosage: 400 MG (BID), INTRAVENOUS. During the same period patient was treated with CLINDAMYCIN PHOSPHATE, TIENAM, LOXONIN, VENOGLOBULIN, MODACIN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4863896-5
Vfend side effect was reported by a Physician from JAPAN on Dec 06, 2005. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with pulmonary mycosis, lung infection, pyrexia and was treated with Vfend. After drug was administered, patient experienced the following side effects: dialysis
, hepatic function abnormal, renal failure acute. Vfend dosage: 400 MG (BID), INTRAVENOUS. During the same period patient was treated with CLINDAMYCIN PHOSPHATE, TIENAM, LOXONIN, VENOGLOBULIN, MODACIN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4868844-X
Vfend side effect was reported by a Physician from JAPAN on Dec 13, 2005. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with pulmonary mycosis, lung infection, pyrexia and was treated with Vfend. After drug was administered, patient experienced the following side effects: dehydration, diabetes mellitus inadequate control, fungal infection
, haemodialysis, hepatic function abnormal, hyperglycaemia, lung infection, pneumonia , renal failure acute. Vfend dosage: 400 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with CLINDAMYCIN PHOSPHATE, TIENAM, LOXONIN, VENOGLOBULIN, MODACIN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4985828-1
Vfend side effect was reported by a Pharmacist from JAPAN on Apr 10, 2006. Female patient, 77 years of age, weighting 97.44 lb, was diagnosed with pneumonitis cryptococcal and was treated with Vfend. After drug was administered, patient experienced the following side effects: anorexia, hepatic function abnormal, nausea
, shunt thrombosis. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), ORAL. During the same period patient was treated with PREDNISOLONE, TIENAM, DIFLUCAN, NORVASC, LASIX, CLARITHROMYCIN, SIGMART, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4996174-4
Vfend side effect was reported by a Physician from JAPAN on Apr 21, 2006. Female patient, 77 years of age, weighting 97.44 lb, was diagnosed with pneumonitis cryptococcal and was treated with Vfend. After drug was administered, patient experienced the following side effects: anorexia, hepatic function abnormal, nausea
, oral intake reduced, shunt occlusion, shunt thrombosis. Vfend dosage: 600 MG (300 MG, 2 IN 1 D), ORAL. During the same period patient was treated with PREDNISOLONE, TIENAM, DIFLUCAN, NORVASC, LASIX, CLARITHROMYCIN, SIGMART, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4939522-3
Vfend side effect was reported by a Physician from JAPAN on Feb 23, 2006. Male patient, 76 years of age, weighting 88.18 lb, was diagnosed with pneumonia aspergillus and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood potassium increased, cyanopsia, haemolysis, hepatic function abnormal, infection
, refusal of treatment by patient. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with LIPITOR, ASPIRIN, MAGNESIUM OXIDE, SINGULAIR, ENALAPRIL MALEATE, MUCOBULIN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4774923-8
Vfend side effect was reported by a Physician from JAPAN on Sept 07, 2005. Female patient was diagnosed with pneumonia
, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: dehydration, diabetes mellitus inadequate control, dialysis , hepatic function abnormal, renal failure acute. Vfend dosage: unknown. During the same period patient was treated with CLINDAMYCIN PHOSPHATE, MEROPEN, NSAID. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5772938-4
Vfend side effect was reported by a Physician from JAPAN on June 02, 2008. Male patient, 73 years of age, was diagnosed with meningitis cryptococcal and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, c-reactive protein increased, eyelid ptosis, hepatic function abnormal, muscular weakness. Vfend dosage: DAILY DOSE:800MG. During the same period patient was treated with POTASSIUM CHLORIDE, MAGNESIUM OXIDE, LENDORMIN, FAMOTIDINE, AMBISOME, FLUCYTOSINE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5511749-1
Vfend side effect was reported by a Physician from JAPAN on Oct 30, 2007. Female patient, weighting 112.4 lb, was diagnosed with meningitis cryptococcal, rheumatoid arthritis
and was treated with Vfend. After drug was administered, patient experienced the following side effects: eyelid ptosis, hepatic function abnormal, rash . Vfend dosage: unknown. During the same period patient was treated with RHEUMATREX, IMURAN, MOBIC, TAKEPRON, METHOTREXATE, PREDNISOLONE, AMBISOME. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5780921-8
Vfend side effect was reported by a Physician from JAPAN on June 09, 2008. Male patient, weighting 117.7 lb, was diagnosed with meningitis cryptococcal and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, c-reactive protein increased, eyelid ptosis, hepatic function abnormal, muscular weakness. Vfend dosage: DAILY DOSE:800MG. During the same period patient was treated with POTASSIUM CHLORIDE, MAGNESIUM OXIDE, LENDORMIN, FAMOTIDINE, AMBISOME, FLUCYTOSINE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5792589-5
Vfend side effect was reported by a Physician from JAPAN on June 17, 2008. Male patient, weighting 116.8 lb, was diagnosed with meningitis cryptococcal and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, c-reactive protein increased, eyelid ptosis, hepatic function abnormal, muscular weakness. Vfend dosage: DAILY DOSE:800MG. During the same period patient was treated with POTASSIUM CHLORIDE, MAGNESIUM OXIDE, LENDORMIN, FAMOTIDINE, AMBISOME, FLUCYTOSINE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #4988047-8
Vfend side effect was reported by a Pharmacist from JAPAN on Apr 14, 2006. Male patient, 80 years of age, was diagnosed with ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergilloma, condition aggravated, hepatic function abnormal. Vfend dosage: unknown. During the same period patient was treated with PLETAL. Patient died on 04/15/2006.
Vfend Side Effects Report #5161771-2
Vfend side effect was reported by a Physician from JAPAN on Nov 08, 2006. Male patient, 74 years of age, weighting 114.4 lb, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: depressed level of consciousness, hepatic function abnormal, hyponatraemia, malaise, somnolence. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ALDACTONE, MICARDIS, ROXATIDINE ACETATE, PREDNISOLONE, BIO THREE, FUNGIZONE, POVIDONE IODINE, ACTONEL. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5042871-4
Vfend side effect was reported by a Pharmacist from JAPAN on June 13, 2006. Male patient, 60 years of age, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood alkaline phosphatase abnormal, blood lactate dehydrogenase abnormal, cardiac failure, hepatic function abnormal. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with THYRADIN, DIOVAN, BASEN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5282248-X
Vfend side effect was reported by a Physician from JAPAN on Mar 20, 2007. Male patient, 14 years of age, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: hepatic function abnormal, inappropriate antidiuretic hormone secretion. Vfend dosage: DAILY DOSE:500MG. Patient recovered.Vfend Side Effects Report #5298344-7
Vfend side effect was reported by a Physician from JAPAN on Apr 04, 2007. Male patient, 14 years of age, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: hepatic function abnormal, inappropriate antidiuretic hormone secretion. Vfend dosage: DAILY DOSE:500MG. Patient recovered.Vfend Side Effects Report #4866926-X
Vfend side effect was reported by a Physician from JAPAN on Dec 14, 2005. Female patient, 66 years of age, was diagnosed with fungaemia, shock, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, pneumonia
. Vfend dosage: 360 MG, INTRAVENOUS. During the same period patient was treated with COTRIM, CIPROFLOXACIN HYDROCHLORIDE, GANCICLOVIR. Patient died.Vfend Side Effects Report #5915793-1
Vfend side effect was reported by a Consumer or non-health professional from JAPAN on Sept 29, 2008. Male patient, 54 years of age, weighting 143.3 lb, was diagnosed with diffuse alveolar damage and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, hepatic function abnormal. Vfend dosage: DAILY DOSE:3.1MG/KG. During the same period patient was treated with FLUCONAZOLE, FINIBAX, VANCOMYCIN HYDROCHLORIDE, AMINO ACIDS, HYDROCORTISONE SUCCINATE, OMEPRAZOLE, ALLOPURINOL, PLATELETS. Patient died on 04/23/2008.
Vfend Side Effects Report #4757810-0
Vfend side effect was reported by a Physician from JAPAN on Aug 17, 2005. Male patient, 69 years of age, was diagnosed with candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: hepatic function abnormal, retinal detachment. Vfend dosage: unknown. Patient recovered.
Vfend Side Effects Report #4800264-6
Vfend side effect was reported by a Physician from JAPAN on Sept 30, 2005. Male patient, 52 years of age, weighting 132.9 lb, was diagnosed with candida pneumonia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood beta-d-glucan increased, hepatic function abnormal. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INRAVENOUS. During the same period patient was treated with DIFLUCAN, FUNGIZONE, PREDNISONE, NEORAL, FAMOTIDINE, SUCRALFATE, AMOBAN. Patient recovered.
Vfend Side Effects Report #4874863-X
Vfend side effect was reported by a Physician from JAPAN on Dec 22, 2005. Male patient, 85 years of age, weighting 76.50 lb, was diagnosed with bronchopulmonary aspergillosis, staphylococcal sepsis and was treated with Vfend. After drug was administered, patient experienced the following side effects: anaemia, dysarthria, dyskinesia, dysphagia, hallucination, hepatic function abnormal, jaundice
, joint dislocation, mouth haemorrhage. Vfend dosage: 200 MG (200 MG 1 IN 1 D) INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, TAZOCIN, PREDNISOLONE, FOSLFUCONAZOLE, ALENDRONATE, ETODOLAC, NIZATIDINE. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4877998-0
Vfend side effect was reported by a Physician from JAPAN on Dec 28, 2005. Male patient, 85 years of age, weighting 76.50 lb, was diagnosed with bronchopulmonary aspergillosis, staphylococcal sepsis and was treated with Vfend. After drug was administered, patient experienced the following side effects: anaemia, cerebral infarction, dysarthria, dyskinesia, dysphagia, fungus serology test positive, hallucination, hepatic function abnormal, hydrocephalus
. Vfend dosage: 200 MG (200 MG, 1 IN 1 D), INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, TAZOCIN, PREDNISOLONE, TICLOPIDINE, FOSFLUCONAZOLE, ALENDRONATE, ETODOLAC, NIZATIDINE. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5128302-4
Vfend side effect was reported by a Physician from JAPAN on Sept 28, 2006. Female patient, 71 years of age, weighting 108.9 lb, was diagnosed with bronchopulmonary aspergillosis, lung neoplasm malignant and was treated with Vfend. After drug was administered, patient experienced the following side effects: gamma-glutamyltransferase increased, hepatic function abnormal, malaise, nausea
, oral intake reduced. Vfend dosage: 400 MG (2 IN 1 D), ORAL; 300 MG, INTRAVENOUS. During the same period patient was treated with TAXOTERE, PARAPLATIN, ITRACONAZOLE. Patient recovered.Vfend Side Effects Report #5044556-7
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia , respiratory disorder. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.Vfend Side Effects Report #5045942-1
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, opportunistic infection. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.Vfend Side Effects Report #5018189-2
Vfend side effect was reported by a Physician from JAPAN on May 17, 2006. Male patient, 51 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic function abnormal, interstitial lung disease, shock. Vfend dosage: 300 MG, INTRAVENOUS. During the same period patient was treated with MINOCYCLINE, GANCICLOVIR, MEROPEN, ACYCLOVIR, BACTRIM. Patient died on 10/31/2005.
Vfend Side Effects Report #5324376-6
Vfend side effect was reported by a Consumer or non-health professional from JAPAN on May 02, 2007. Male patient, 50 years of age, weighting 114.6 lb, was diagnosed with bronchopulmonary aspergillosis, infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: hepatic function abnormal, renal impairment. Vfend dosage: unknown. During the same period patient was treated with MICAFUNGIN, FUNGIZONE, BAKTAR. Patient died on 12/01/2006.Vfend Side Effects Report #5344489-2
Vfend side effect was reported by a Consumer or non-health professional from JAPAN on May 23, 2007. Male patient, 50 years of age, weighting 114.6 lb, was diagnosed with bronchopulmonary aspergillosis, infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: adult t-cell lymphoma/leukaemia, hepatic function abnormal, renal impairment. Vfend dosage: unknown. During the same period patient was treated with MICAFUNGIN, FUNGIZONE, BAKTAR. Patient died on 12/17/2006.Vfend Side Effects Report #5266584-9
Vfend side effect was reported by a Physician from JAPAN on Mar 05, 2007. Male patient, weighting 151.0 lb, was diagnosed with bronchopulmonary aspergillosis, nausea
, cough, constipation , reflux oesophagitis, radiation pneumonitis, anorexia, malaise, radiation oesophagitis and was treated with Vfend. After drug was administered, patient experienced the following side effects: hallucination, hepatic function abnormal, hypokalaemia. Vfend dosage: unknown. During the same period patient was treated with NAUZELIN, CODEINE PHOSPHATE, MAGNESIUM OXIDE, FAMOTIDINE, RINDERON, STROCAIN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #5019747-1
Vfend side effect was reported by a Physician from JAPAN on May 22, 2006. Female patient, 61 years of age, was diagnosed with aspergillosis, brain abscess and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, myelodysplastic syndrome. Vfend dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, MICAFUNGIN. Patient died.
Vfend Side Effects Report #5097573-5
Vfend side effect was reported by a Pharmacist from JAPAN on Aug 22, 2006. Female patient, 18 years of age, weighting 97.00 lb, was diagnosed with aspergillosis, immunosuppression and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute graft versus host disease in liver, hepatic function abnormal, liver disorder, visual disturbance. Vfend dosage: unknown. During the same period patient was treated with CYCLOSPORINE, FLUCONAZOLE, FOSFLUCONAZOLE, SULFAMETHOXAZOLE, BETAMETHASONE. Patient recovered.
Vfend Side Effects Report #5006755-X
Vfend side effect was reported by a Consumer or non-health professional from AUSTRIA on May 03, 2006. Female patient was diagnosed with aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: blister, cataract
, cholelithiasis, chronic obstructive pulmonary disease, food interaction, hepatic function abnormal, hip fracture, infection . Vfend dosage: 400 MG. During the same period patient was treated with SYMBICORT, AZITHROMYCIN, PREDNISOLONE. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4818923-8
Vfend side effect was reported by a Physician from JAPAN on Oct 20, 2005. Female patient, 77 years of age, was diagnosed with aspergilloma and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic function abnormal, lung neoplasm malignant. Vfend dosage: 400 MG, INTRAVENOUS. Patient recovered.
Vfend Side Effects Report #5146288-3
Vfend side effect was reported by a Physician from JAPAN on Oct 19, 2006. Male patient, 87 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, interstitial lung disease. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, IMMUNOSUPPRESSIVE AGENTS. Patient died on 10/01/2006.
Vfend Side Effects Report #5077842-5
Vfend side effect was reported by a Pharmacist from JAPAN on July 25, 2006. Female patient, 18 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Vfend dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient recovered.